The BMT CTN wants investigators to be aware of available funding opportunities for their own or BMT CTN projects. Current funding opportunities may be found here:
- Notice of Special Interest (NOSI): Pulmonary Complications of Hematopoietic Stem Cell Transplantation (HCT): https://grants.nih.gov/grants/guide/notice-files/NOT-HL-23-116.html
- Published on November 1 2023, active until Jan 8 2027, with an expanded scope to include:
1. Recipients of autologous stem cell transplant
2. Adults and children
3. Devices
4. Mechanistic Clinical trials (R01)
- Published on November 1 2023, active until Jan 8 2027, with an expanded scope to include:
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional): https://grants.nih.gov/grants/guide/pa-files/PAR-21-079.html, National Heart, Lung, and Blood Institute
- Prior to application, applicants are strongly advised to contact:
Andrei L. Kindzelski, MD, PhD
Division of Blood Diseases and Resources,
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0070
Email: kindzelskial@nhlbi.nih.gov
- Prior to application, applicants are strongly advised to contact:
- To search for current NIH grant funding opportunities: https://grants.nih.gov/funding/searchguide/index.html#/
To request a BMT CTN letter of support for an investigator-initiated study using BMT CTN data/samples, or for BMT CTN budget, study design, biospecimen/data availability consultation, please contact bmtctn@emmes.com. As a reminder, to obtain BMT CTN data/samples, approval is needed by the BMT CTN Executive Committee. Additional information may be found on the Proposals for Clinical Trials & Correlative Studies page.